Get the Stockscreener App
1.74
4.40%
-0.08
Pre-market:
1.74
Accuray Inc stock is traded at $1.74, with a volume of 354.12K.
It is down -4.40% in the last 24 hours and down -23.68% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$1.82
Open:
$1.82
24h Volume:
354.12K
Relative Volume:
0.52
Market Cap:
$178.93M
Revenue:
$447.48M
Net Income/Loss:
$-14.55M
P/E Ratio:
-11.60
EPS:
-0.15
Net Cash Flow:
$7.61M
1W Performance:
-4.92%
1M Performance:
-23.68%
6M Performance:
-20.55%
1Y Performance:
-35.07%
1-Day Range:
$1.73
$1.82
1-Week Range:
$1.73
$1.89
52-Week Range:
$1.40
$2.95
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
1.74 | 178.93M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray (NASDAQ:ARAY) Is Experiencing Growth In Returns On Capital - Yahoo Finance
Accuray Executives Set for Strategic Fireside Chat at Major Roth Investor Conference - StockTitan
Rhumbline Advisers Reduces Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray (ARAY) Down 32% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Accuray Incorporated to Host Earnings Call - ACCESS Newswire
Here's Why You Should Hold Accuray Stock In Your Portfolio For Now - Barchart
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now - Yahoo Finance
Accuray (NASDAQ:ARAY) Upgraded by StockNews.com to “Buy” Rating - Defense World
Spine Surgery Robots Market Projected To Witness Substantial Growth 2025-2032:Medtronic, Zimmer Biomet, - EIN News
Accuray (NASDAQ:ARAY) Stock Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Accuray appoints new COO with extensive industry experience - MSN
Will Accuray’s Struggles Lead to a Surprising Comeback? - Jomfruland.net
The past three years for Accuray (NASDAQ:ARAY) investors has not been profitable - Yahoo Finance
Head to Head Survey: Femasys (NASDAQ:FEMY) & Accuray (NASDAQ:ARAY) - Defense World
Accuray (NASDAQ:ARAY) Cut to "Hold" at StockNews.com - MarketBeat
Roth Capital Has Pessimistic Outlook of Accuray Q3 Earnings - MarketBeat
Accuray Incorporated (NASDAQ:ARAY) Sees Significant Growth in Short Interest - MarketBeat
Accuray (NASDAQ:ARAY) Lowered to “Hold” Rating by StockNews.com - Defense World
Equities Analysts Set Expectations for Accuray Q3 Earnings - Defense World
Accuray (NASDAQ:ARAY) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
SG Americas Securities LLC Has $89,000 Stock Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
The time has not yet come to remove your chips from the table: Accuray Inc (ARAY) - SETE News
Accuray’s Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
ARAY Stock Update: Accuray Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
Accuray (NASDAQ:ARAY) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Results: Accuray Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance UK
Caprock Group LLC Lowers Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray appoints new COO with extensive industry experience By Investing.com - Investing.com Canada
Accuray Appoints Leonel Peralta as Chief Operations Officer - TipRanks
Radiation Oncology Devices Market Overall Study Report - openPR
Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Accuray Reports Strong Growth and Raises Guidance - TipRanks
ARAY Stock Up as Q2 Earnings & Revenues Beat Estimates, Margins Up - Nasdaq
Accuray Inc (NASDAQ: ARAY): Blank Check On Growth? - Stocks Register
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript - Insider Monkey
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Prod - GuruFocus.com
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Product Revenue and Strategic ... - Yahoo Finance
Accuray raises FY 2025 revenue guidance to $463M-$475M, driven by strong China growth - MSN
Accuray Incorporated Shows Improved Financial Performance - TipRanks
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates - MSN
Accuray: Fiscal Q2 Earnings Snapshot - Huron Daily Tribune
ACCURAY Earnings Results: $ARAY Reports Quarterly Earnings - Nasdaq
Accuray Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Accuray Inc Q2 Earnings: EPS of $0.03 Beats Estimate, Revenue Su - GuruFocus.com
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Accuray Q2 Earnings Summary & Key Takeaways - Benzinga
Accuray Reports Strong Q2 Financial Results for 2025 - TipRanks
Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q2 Revenue $116.2M, vs. FactSet Est of $110.3M - Marketscreener.com
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance - PR Newswire
Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex
A look into Accuray Inc (ARAY)’s deeper side - SETE News
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pervaiz Ali | SVP Chief Financial Officer |
Sep 04 '24 |
Sale |
2.06 |
8,404 |
17,276 |
394,138 |
| Pervaiz Ali | SVP Chief Financial Officer |
Jun 04 '24 |
Sale |
1.70 |
2,701 |
4,597 |
402,542 |
| WHITTERS JOSEPH E | Director |
May 29 '24 |
Buy |
1.58 |
50,000 |
79,000 |
561,053 |
| WHITTERS JOSEPH E | Director |
May 28 '24 |
Buy |
1.54 |
50,000 |
77,045 |
511,053 |
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):